These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 34089866)

  • 1. Phytochemical inhibitors of the NLRP3 inflammasome for the treatment of inflammatory diseases.
    Özenver N; Efferth T
    Pharmacol Res; 2021 Aug; 170():105710. PubMed ID: 34089866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory Role of Berberine, an Isoquinoline Alkaloid, on NLRP3 Inflammasome Activation for the Treatment of Inflammatory Diseases.
    Sarbadhikary P; George BP; Abrahamse H
    Molecules; 2021 Oct; 26(20):. PubMed ID: 34684819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The NLRP3 Inflammasome as a Pharmacological Target.
    Marchetti C
    J Cardiovasc Pharmacol; 2019 Oct; 74(4):285-296. PubMed ID: 31335445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of phytochemicals on NLRP3 inflammasome activation: A review.
    Olcum M; Tastan B; Ercan I; Eltutan IB; Genc S
    Phytomedicine; 2020 Aug; 75():153238. PubMed ID: 32507349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phytochemicals as Novel Therapeutic Strategies for NLRP3 Inflammasome-Related Neurological, Metabolic, and Inflammatory Diseases.
    Pellegrini C; Fornai M; Antonioli L; Blandizzi C; Calderone V
    Int J Mol Sci; 2019 Jun; 20(12):. PubMed ID: 31200447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes.
    Buckley LF; Libby P
    J Cardiovasc Pharmacol; 2019 Oct; 74(4):297-305. PubMed ID: 31356538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic Targeting of NLRP3 Inflammasomes by Natural Products and Pharmaceuticals: A Novel Mechanistic Approach for Inflammatory Diseases.
    Jahan S; Kumar D; Chaturvedi S; Rashid M; Wahajuddin M; Khan YA; Goyal SN; Patil CR; Mohanraj R; Subramanya S; Ojha S
    Curr Med Chem; 2017; 24(16):1645-1670. PubMed ID: 28245768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NLRP3 Inflammasome in Acute Myocardial Infarction.
    Mauro AG; Bonaventura A; Mezzaroma E; Quader M; Toldo S
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):175-187. PubMed ID: 31356555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic regulation of the NLRP3 inflammasome in chronic inflammatory diseases.
    Seok JK; Kang HC; Cho YY; Lee HS; Lee JY
    Arch Pharm Res; 2021 Jan; 44(1):16-35. PubMed ID: 33534121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction.
    Takahashi M
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):188-193. PubMed ID: 31356542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-coding RNAs: The key regulators in NLRP3 inflammasome-mediated inflammatory diseases.
    Feng X; Luo D; Wei G; Zhan F; Hua F; Xu G
    Int Immunopharmacol; 2021 Nov; 100():108105. PubMed ID: 34481143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phytochemical Constituents of
    Buakaew W; Pankla Sranujit R; Noysang C; Thongsri Y; Potup P; Nuengchamnong N; Suphrom N; Usuwanthim K
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33466926
    [No Abstract]   [Full Text] [Related]  

  • 13. The strategies of targeting the NLRP3 inflammasome to treat inflammatory diseases.
    Jiang H; Gong T; Zhou R
    Adv Immunol; 2020; 145():55-93. PubMed ID: 32081200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in the NEK7-licensed NLRP3 inflammasome activation: Mechanisms, role in diseases and related inhibitors.
    Zhao N; Li CC; Di B; Xu LL
    J Autoimmun; 2020 Sep; 113():102515. PubMed ID: 32703754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting NLRP3 (Nucleotide-Binding Domain, Leucine-Rich-Containing Family, Pyrin Domain-Containing-3) Inflammasome in Cardiovascular Disorders.
    Wang Z; Hu W; Lu C; Ma Z; Jiang S; Gu C; Acuña-Castroviejo D; Yang Y
    Arterioscler Thromb Vasc Biol; 2018 Dec; 38(12):2765-2779. PubMed ID: 30571177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Inflammatory Activity of Melatonin: a Focus on the Role of NLRP3 Inflammasome.
    Ashrafizadeh M; Najafi M; Kavyiani N; Mohammadinejad R; Farkhondeh T; Samarghandian S
    Inflammation; 2021 Aug; 44(4):1207-1222. PubMed ID: 33651308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NLRP3 inflammasome as a key driver of vascular disease.
    Takahashi M
    Cardiovasc Res; 2022 Jan; 118(2):372-385. PubMed ID: 33483732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medicinal plants and bioactive natural products as inhibitors of NLRP3 inflammasome.
    Bagherniya M; Khedmatgozar H; Fakheran O; Xu S; Johnston TP; Sahebkar A
    Phytother Res; 2021 Sep; 35(9):4804-4833. PubMed ID: 33856730
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting the NLRP3 Inflammasome in Neuroinflammation: Health Promoting Effects of Dietary Phytochemicals in Neurological Disorders.
    Hung WL; Ho CT; Pan MH
    Mol Nutr Food Res; 2020 Feb; 64(4):e1900550. PubMed ID: 31675164
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular Pharmacology of the NLRP3 Inflammasome.
    Abbate A; Booz GW
    J Cardiovasc Pharmacol; 2019 Sep; 74(3):173-174. PubMed ID: 31498192
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.